These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22365290)

  • 1. From good to good deal: value-focused research.
    Duszak R
    J Vasc Interv Radiol; 2012 Mar; 23(3):315-6. PubMed ID: 22365290
    [No Abstract]   [Full Text] [Related]  

  • 2. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective.
    Ray CE; Battaglia C; Libby AM; Prochazka A; Xu S; Funaki B
    J Vasc Interv Radiol; 2012 Mar; 23(3):306-14. PubMed ID: 22277271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the value proposition for IR.
    Ray CE
    J Vasc Interv Radiol; 2014 Apr; 25(4):575. PubMed ID: 24674215
    [No Abstract]   [Full Text] [Related]  

  • 4. Calculation of operating expenses for conventional transarterial chemoembolization in an academic medical center: a step toward defining the value of transarterial chemoembolization.
    Beheshti MV; Meek J
    J Vasc Interv Radiol; 2014 Apr; 25(4):567-74. PubMed ID: 24462006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
    J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions.
    McCarthy CJ; Zhu AX; Alansari SA; Oklu R
    J Am Coll Radiol; 2016 Aug; 13(8):915-21. PubMed ID: 27325468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interventional therapy for hepatocellular carcinoma].
    Wang JH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):721-3. PubMed ID: 16248940
    [No Abstract]   [Full Text] [Related]  

  • 8. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma.
    Zaydfudim V; Whiteside MA; Griffin MR; Feurer ID; Wright JK; Pinson CW
    Ann Surg Oncol; 2010 Dec; 17(12):3104-11. PubMed ID: 20585872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost Accounting as a Tool for Increasing Cost Transparency in Selective Hepatic Transarterial Chemoembolization.
    Ahmed O; Patel M; Ward T; Sze DY; Telischak K; Kothary N; Hofmann LV
    J Vasc Interv Radiol; 2015 Dec; 26(12):1820-6.e1. PubMed ID: 26521766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on "Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?".
    Lee MW
    Radiology; 2010 Feb; 254(2):633; author reply 634. PubMed ID: 20093536
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan.
    Nguang SH; Wu CK; Liang CM; Tai WC; Yang SC; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Hsu PI; Wu DC; Chuah SK; Hsu CN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis.
    Hiraki T; Sakurai J; Gobara H; Kawamoto H; Mukai T; Hase S; Iguchi T; Fujiwara H; Tajiri N; Shiratori Y; Kanazawa S
    J Vasc Interv Radiol; 2006 Mar; 17(3):583-5. PubMed ID: 16567686
    [No Abstract]   [Full Text] [Related]  

  • 13. Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.
    Wu T; Sun R; Huang Y; Wang Z; Yin X; Zhu Z; Zhao Z; He J
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e107-11. PubMed ID: 26728666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
    Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C
    Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
    Vadot L; Boulin M; Guiu B; Aho LS; Vourc'h M; Musat A; Hillon P; Lepage C; Guignard MH; Fagnoni P
    J Clin Pharm Ther; 2015 Feb; 40(1):83-90. PubMed ID: 25413186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional Radiologic Treatment of Hepatocellular Carcinoma.
    Boyvat F
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):25-30. PubMed ID: 28301995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the treatment options for hepatocellular carcinoma: combining transarterial chemoembolization with radiofrequency ablation.
    Zhu AX; Abou-Alfa GK
    JAMA; 2008 Apr; 299(14):1716-8. PubMed ID: 18398085
    [No Abstract]   [Full Text] [Related]  

  • 19. Medico-economic study of the management of hepatocellular carcinoma by chemo-embolization.
    Clouet J; Audureau D; Lefranc B; Maillard N; Guilé R; Frampas E; Perret C; Grimandi G
    Diagn Interv Imaging; 2014 Apr; 95(4):427-34. PubMed ID: 24231346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RCT of chemoembolization plus rediofrequency ablation versus liver resection for hepatocellular carcinoma].
    Strobel O; Büchler MW
    Chirurg; 2016 Jun; 87(6):533. PubMed ID: 27251481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.